Balasa Dinverno & Foltz’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$3.9M Sell
29,085
-2,861
-9% -$384K 0.25% 41
2022
Q2
$4.89M Buy
31,946
+1,445
+5% +$221K 0.31% 34
2022
Q1
$4.95M Buy
30,501
+5,296
+21% +$859K 0.33% 33
2021
Q4
$3.41M Sell
25,205
-3,831
-13% -$519K 0.22% 46
2021
Q3
$3.13M Sell
29,036
-855
-3% -$92.2K 0.22% 44
2021
Q2
$3.37M Buy
29,891
+399
+1% +$44.9K 0.24% 39
2021
Q1
$3.19M Buy
29,492
+5,382
+22% +$583K 0.26% 39
2020
Q4
$2.58M Buy
24,110
+4,672
+24% +$501K 0.21% 45
2020
Q3
$1.7M Buy
19,438
+2,347
+14% +$206K 0.16% 61
2020
Q2
$1.68M Sell
17,091
-5,832
-25% -$573K 0.19% 52
2020
Q1
$1.75M Buy
22,923
+1,734
+8% +$132K 0.22% 47
2019
Q4
$1.88M Buy
21,189
+958
+5% +$84.8K 0.2% 52
2019
Q3
$1.53M Buy
20,231
+4,299
+27% +$326K 0.18% 56
2019
Q2
$1.16M Sell
15,932
-1,110
-7% -$80.7K 0.14% 73
2019
Q1
$1.37M Sell
17,042
-996
-6% -$80.2K 0.16% 56
2018
Q4
$1.66M Sell
18,038
-867
-5% -$79.9K 0.21% 44
2018
Q3
$1.79M Buy
18,905
+775
+4% +$73.3K 0.2% 41
2018
Q2
$1.68M Buy
18,130
+349
+2% +$32.3K 0.24% 41
2018
Q1
$1.68M Buy
17,781
+511
+3% +$48.4K 0.26% 36
2017
Q4
$1.67M Buy
17,270
+274
+2% +$26.5K 0.25% 39
2017
Q3
$1.51M Buy
16,996
+800
+5% +$71.1K 0.24% 40
2017
Q2
$1.17M Buy
16,196
+1,307
+9% +$94.7K 0.19% 44
2017
Q1
$970K Sell
14,889
-2,082
-12% -$136K 0.16% 52
2016
Q4
$1.06M Buy
16,971
+1,926
+13% +$121K 0.18% 50
2016
Q3
$949K Buy
15,045
+721
+5% +$45.5K 0.17% 54
2016
Q2
$887K Buy
14,324
+1,280
+10% +$79.3K 0.16% 54
2016
Q1
$745K Buy
13,044
+457
+4% +$26.1K 0.13% 57
2015
Q4
$746K Sell
12,587
-487
-4% -$28.9K 0.13% 60
2015
Q3
$711K Sell
13,074
-252
-2% -$13.7K 0.13% 62
2015
Q2
$895K Sell
13,326
-822
-6% -$55.2K 0.15% 45
2015
Q1
$828K Sell
14,148
-757
-5% -$44.3K 0.12% 53
2014
Q4
$975K Buy
14,905
+545
+4% +$35.7K 0.14% 41
2014
Q3
$829K Sell
14,360
-799
-5% -$46.1K 0.13% 49
2014
Q2
$856K Buy
15,159
+287
+2% +$16.2K 0.1% 40
2014
Q1
$764K Sell
14,872
-63
-0.4% -$3.24K 0.09% 43
2013
Q4
$789K Sell
14,935
-5,527
-27% -$292K 0.11% 38
2013
Q3
$915K Buy
20,462
+61
+0.3% +$2.73K 0.15% 32
2013
Q2
$843K Buy
+20,401
New +$843K 0.15% 35